1297366

Andrew Spencer — FEI 3039897835

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 28, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Melbourne (Australia)

Additional Details

Clinical Investigator (CI)